The phenotypic heterogeneity of human natural killer cells: Presence of at least 48 different subsets in the peripheral blood

Scandinavian Journal of Immunology

Volumn 53, Issue 2, 2001, Pages 103-110

  Jonges, L E ^a,b   Albertsson, P ^a   Van Vlierberghe, R L P ^a   Johansson, B R ^a   Van De Velde, C J H ^a   Fleuren, G J ^a   Nannmark, U ^a   Kuppen, P J K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CELL SURFACE MARKER;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL STRUCTURE; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, SURFACE; BLOOD CELLS; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED;

EID: 0035125541     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00838.x     Document Type: Article

References (37)

1. Natural killer cell receptors
2. Human uterine natural killer cells
3. Natural killer cells: Endothelial interactions, migration, and target cell recognition
4. Natural killer cells and recognition of MHC class I molecules: New perspectives and challenges in immunology
5. Costimulation of human natural killer cell proliferation: Role of accessory cytokines and cell contact-dependent signals
6. Dissection of the lymphokine-activated killer phenomenon.Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis
7. Positive selection of CD56+ lymphocytes by magnetic cell sorting
8. The biology of natural killer cells: Insights into the molecular basis of function
9. Biology of natural killer cells
10. Functional heterogeneity of Leu19′bright′ + and Leu19"dim"+ lymphokine-activated killer cells
11. bright+ natural killer cell subpopulations
12. Biology and clinical relevance of human natural killer cells
13. Comparative studies of human FcRIII-positive and negative natural killer cells
14. Numerical and functional characteristics of lymphocyte subsets in centenarians
15. Redirecting the cellular immune response
16. Early stages in the development of human T, natural killer and thymic dendritic cells
17. Natural killer cell differentiation: Insights from knockout and transgenic mouse models and In vitro systems
18. Inositol triphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX-34: Possible signaling role for the OX-34 determinant during activation by target cells
19. Participation of CD1 1a-c/ CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3- negative large granular lymphocytes
20. NK cell receptors
21. Regulation of immune responses through inhibitory receptors
22. Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity
23. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging
24. Phenotypical and functional analyses of natural killer cells from low NK activity individuals among healthy and patient populations
25. + mononuclear blood cells
26. Natural killer cells: Their role in defence against disease
27. Flow-cytometric analysis of peripheral blood lymphocytes in patients with chronic idiopathic neutropenia of adults
28. Adverse effects of intraportal chemotherapy on natural killer cell activity in colorectal cancer patients
29. CD56+bright and CD56+dim natural killer cells in patient with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clongenic natural killer cells, and exhibit decreased proliferation on a per cell basis
30. Increased CD56+ natural killer cells and related cytokines in major depression
31. dim natural killer cell subsets
32. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells In vivo
33. Interleukin 2 receptors in resting lymphocytes
34. The CD56bright human NK subset is the most potent Nk producer of macrophage activating factors
35. Expression of integrins and other adhesion molecules on NK cells: Impact of IL-2 on short- and long-term cultures
36. A distinct distribution of natural killer cell subgroups in human tissues and blood
37. + natural killer cell subset during HIV infection